GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Ship Healthcare Holdings 3360.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,512

+3.57%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥718.16bn

FY2017FY2026

Net income

¥13.39bn

FY2017FY2026

Free cash flow

¥17.76bn

FY2017FY2026

Shareholders' equity

¥151.07bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥718.16bn¥678.23bn¥630.99bn¥572.28bn¥514.35bn¥497.16bn¥484.39bn¥444.05bn¥425.57bn¥408.49bn
Gross profit¥66.70bn¥66.74bn¥65.61bn¥60.62bn¥53.64bn¥54.49bn¥49.63bn¥46.65bn¥47.08bn¥44.49bn
Research and development—¥460.0m¥418.0m¥380.0m¥428.0m¥361.0m¥341.0m¥263.0m¥350.0m¥333.0m
Operating income¥24.34bn¥24.79bn¥24.45bn¥21.16bn¥20.74bn¥21.17bn¥19.18bn¥17.81bn¥18.27bn¥15.92bn
Net income¥13.39bn¥15.13bn¥13.80bn¥12.06bn¥12.17bn¥12.28bn¥11.80bn¥11.23bn¥10.35bn¥9.41bn
Diluted earnings per share145.70164.39146.25127.84116.99118.54113.56107.31102.3493.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥385.11bn¥381.70bn¥387.56bn¥381.98bn¥335.07bn¥334.50bn¥308.87bn¥299.33bn¥285.53bn¥264.12bn
Cash and short-term investments¥80.57bn¥77.50bn¥85.07bn¥83.94bn¥73.90bn¥77.26bn¥87.32bn¥72.39bn¥59.64bn¥53.55bn
Total liabilities¥232.68bn¥231.42bn¥245.33bn¥250.86bn¥212.75bn¥219.40bn¥204.19bn¥201.59bn¥183.17bn¥170.49bn
Debt¥30.37bn¥39.30bn¥59.87bn¥75.78bn¥63.41bn¥67.06bn¥69.78bn¥72.75bn¥46.37bn¥45.07bn
Shareholders' equity¥151.07bn¥149.08bn¥139.53bn¥128.04bn¥118.29bn¥111.44bn¥101.78bn¥95.42bn¥99.88bn¥91.39bn
Shares outstanding92m92m94m94m104m104m104m105m101m101m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥22.04bn¥20.38bn¥31.61bn¥14.11bn¥12.43bn¥19.77bn¥24.01bn¥10.53bn¥20.20bn¥15.19bn
Capital spending−¥4.28bn−¥3.82bn−¥3.19bn−¥3.91bn−¥3.47bn−¥5.01bn−¥3.81bn−¥2.77bn−¥5.71bn−¥5.51bn
Free cash flow¥17.76bn¥16.56bn¥28.42bn¥10.20bn¥8.96bn¥14.76bn¥20.20bn¥7.77bn¥14.50bn¥9.68bn
Dividends paid−¥5.47bn−¥4.72bn−¥3.96bn−¥3.87bn−¥3.77bn−¥3.56bn−¥3.33bn−¥3.24bn−¥3.04bn−¥2.72bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥176.36bn¥195.75bn¥189.03bn¥170.07bn¥163.31bn¥185.96bn¥182.24bn¥154.81bn
Gross profit¥13.64bn¥20.60bn¥16.78bn¥15.59bn¥13.73bn¥20.56bn¥18.18bn¥14.32bn
Operating income¥2.77bn¥10.01bn¥6.27bn¥5.23bn¥2.95bn¥9.66bn¥7.38bn¥4.24bn
Net income¥2.09bn¥4.01bn¥3.95bn¥3.40bn¥2.03bn¥4.61bn¥4.98bn¥2.47bn
Diluted earnings per share22.7243.6542.9336.9622.0650.0952.7826.22
Total assets¥371.79bn¥385.11bn¥388.94bn¥360.04bn¥367.17bn¥381.70bn¥378.43bn¥362.22bn
Cash and short-term investments¥82.75bn¥80.57bn¥78.46bn¥72.81bn¥80.57bn¥77.50bn¥72.96bn¥80.35bn
Debt¥1.37bn¥30.37bn¥763.0m¥30.28bn¥1.29bn¥37.60bn¥762.0m¥46.41bn
Shareholders' equity¥146.83bn¥151.07bn¥148.06bn¥145.03bn¥145.32bn¥149.08bn¥145.49bn¥140.42bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.9%7.6%8.9%
Operating income4.8%2.8%5.6%
Net income3.6%1.8%4.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin9.6%10.0%10.2%10.4%
Operating margin3.5%3.6%3.8%3.9%
Net margin2.0%2.1%2.2%2.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings17.416.015.118.823.022.625.323.519.820.1
Price to sales0.30.40.30.40.50.60.60.60.50.5

Dividends and splits

Per share, in the currency the company pays

Paid for 17 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year118.0050.0042.0041.0040.0037.5035.0032.00
  • 2-for-1 split · 30 Mar 2021
  • 100-for-1 split · 28 Sept 2010
  • 5-for-1 split · 27 Jun 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.